APAC / Medtech's Post-COVID Paradigm
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine…
|
Editor
Articles:
MEA / Pfizer’s Saudi Transformation; Urgent Call for Arab Import Reform; Hikma & Tabuk Deals
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi…
USA / NORD COO on Health Equity's Vital Importance for Rare Disease Patients
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…
Global / Top 5 CDMOs
As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last…
Germany / STADA’s Bold Bets on M&A
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
USA / Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
Vaccines / IFPMA's Thomas Cueni on why "#TeamVaccines is all of us"
Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights…
Cell & Gene Therapy / Collaborative Spirit
One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they…
USA / 5 Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan…
China / HiFiBiO CEO on the Keys to Global Biotech Success
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T:…
Europe / After Brexit: Focus on the New Pharmaceutical Strategy for Europe
Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the…
China / New Drug Approvals 2020
Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi…